📊 Score Breakdown
Offering Ability
100
Cash Runway
95
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌩️
Severe
Multiple high-probability dilution events detected
79%
💰 Capital Raise
93%
• Critical: only 0.4 months cash remaining
• Active shelf registration ($300M, 585% of market cap)
🔄 Reverse Split
70%
• 50-day avg $0.98 below $1 exchange minimum
• Only 0 months cash — financial pressure
🔁 Convertible Conversion
60%
• Major convertible overhang: 3045% potential dilution
• Convertible risk score very high (85/100)
💹 Market Data
Market Cap$51.29M
Shares Outstanding46.60M
FloatN/A
Cash$1.89M
Debt$5.05M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest42.8K
Days to Cover2.2
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Sep 30, 2025
xbrl
XBRL WARRANT
Sep 30, 2022
6-K
8K EVENT
Apr 17, 2026
424B5
ATM
Apr 16, 2026
EFFECT
EFFECT
Apr 01, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for XHG
📊 XHG FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XHG Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.